Learn more

BEIJING TIDE PHARMACEUTICAL CO LTD

Overview
  • Total Patents
    138
  • GoodIP Patent Rank
    12,290
  • Filing trend
    0.0%
About

BEIJING TIDE PHARMACEUTICAL CO LTD has a total of 138 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2010. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are ARVINAS INC, CASTRO ALFREDO C and PYRAMID BIOSCIENCES INC.

Patent filings per year

Chart showing BEIJING TIDE PHARMACEUTICAL CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zhou Liying 82
#2 Zhao Yanping 81
#3 Liu Yanan 57
#4 Wang Hongjun 52
#5 Jiang Yuanyuan 49
#6 Li Xiang 41
#7 Lu Di 35
#8 Li Gong 34
#9 Xiao Xuan 23
#10 Wang Yeming 21

Latest patents

Publication Filing date Title
WO2021036922A1 Compound inhibiting and inducing degradation of egfr and alk
WO2020259528A1 Method for treating idiopathic pulmonary fibrosis
CN112047938A 2,4, 6-trisubstituted pyrimidine compounds as ATR kinase inhibitors
WO2020244607A1 P2x3 and/or p2x2/3 receptor antagonist, pharmaceutical composition containing same, and use thereof
WO2020221276A1 Salt of diaminopyrimidine compounds, and solid form thereof, preparation method therefor and use thereof
WO2020221277A1 Method for treating endometriosis-associated pain by using diaminopyrimidine compound
WO2020221274A1 Method for treating cough by using diaminopyrimidine compound
WO2020221275A1 Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof
WO2020177587A1 Method for treating fatty liver disease and/or steatohepatitis
WO2020094111A1 Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and use thereof
CN112225657A Preparation method of flurbiprofen
CN111741748A Pregabalin sustained-release composition and preparation method thereof
CN110567947A Kit for detecting activity of phosphatidized recombinant human superoxide dismutase
CN111999157A Pretreatment method for detecting content of main drug and related substances in sustained-release preparation
EP3770148A1 Receptor inhibitor, pharmaceutical composition comprising same, and use thereof
CN109932445A A kind of evaluation method of a variety of charge isomer N sugar chain structures of glycoprotein
CN109932444A A kind of evaluation method of a variety of charge isomer posttranslational modifications of glycoprotein
CN109932516A A kind of analysis method of appraiser's Follicle Stimulating Hormone Receptors affinity
CA3091300A1 Receptor inhibitors, pharmaceutical compositions comprising the same, and usage thereof
CN111388418A Pharmaceutical composition containing ropivacaine or pharmaceutical salt thereof